Flexion Therapeutics, Inc. Financing Cash Flow
Flexion Therapeutics, Inc. reported Financing Cash Flow of $20.33 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-11-12
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $25.46M.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was -$3.66M, a 103.73% decline year-over-year.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was -$1.47M, a 107.36% decline year-over-year.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $907.00K, a 63.69% decline year-over-year.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $118.78M, a 309.31% increase from fiscal 2019.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $29.02M.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2018 was -$6.33M.
- Flexion Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2016 was $163.20M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $25.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $21.80M derived: sum of 2 quarters · filed 2021-11-12 | $20.33M 10-Q · filed 2021-11-12 | $21.23M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$5.13M 10-Q · filed 2021-08-04 | -$4.23M derived: sum of 3 quarters · filed 2021-08-04 | -$4.44M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | -$1.47M 10-Q · filed 2021-05-12 | -$565.00K derived: sum of 2 quarters · filed 2021-05-12 | -$780.00K derived: sum of 3 quarters · filed 2021-11-12 | $97.29M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $692.00K derived: sum of 2 quarters · filed 2021-11-12 | $98.77M derived: sum of 3 quarters · filed 2021-11-12 | $118.78M 10-K · filed 2021-03-10 |
| 2020-09-30 | -$215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $97.86M derived: sum of 2 quarters · filed 2021-11-12 | $117.87M 10-Q · filed 2021-11-12 | $120.37M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $98.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $118.08M 10-Q · filed 2021-08-04 | $120.58M derived: sum of 3 quarters · filed 2021-08-04 | $151.06M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $20.01M 10-Q · filed 2021-05-12 | $22.51M derived: sum of 2 quarters · filed 2021-05-12 | $52.99M derived: sum of 3 quarters · filed 2021-05-12 | $51.53M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $32.98M derived: sum of 2 quarters · filed 2021-03-10 | $31.52M derived: sum of 3 quarters · filed 2021-03-10 | $29.02M 10-K · filed 2021-03-10 |
| 2019-09-30 | $30.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $29.02M derived: sum of 2 quarters · filed 2020-11-04 | $26.52M 10-Q · filed 2020-11-04 | $24.67M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$3.96M 10-Q · filed 2020-08-05 | -$5.81M derived: sum of 3 quarters · filed 2021-03-10 | -$8.19M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$2.50M 10-Q · filed 2020-05-07 | -$4.35M derived: sum of 2 quarters · filed 2021-03-10 | -$6.73M derived: sum of 3 quarters · filed 2021-03-10 | -$6.74M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$4.23M derived: sum of 2 quarters · filed 2021-03-10 | -$4.24M derived: sum of 3 quarters · filed 2021-03-10 | -$6.33M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$2.39M derived: sum of 2 quarters · filed 2019-11-07 | -$4.47M 10-Q · filed 2019-11-07 | $126.64M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$2.09M 10-Q · filed 2019-08-06 | $129.02M derived: sum of 3 quarters · filed 2020-05-20 | $128.14M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | -$2.09M 10-Q · filed 2019-05-08 | $129.03M derived: sum of 2 quarters · filed 2020-05-20 | $128.15M derived: sum of 3 quarters · filed 2020-05-20 | |
| 2017-12-31 | $131.12M derived: 8-K 12 month − 10-Q 9 month · filed 2020-05-20 | $130.24M derived: sum of 2 quarters · filed 2020-05-20 | $323.50M 8-K · filed 2020-05-20 | |
| 2017-09-30 | -$880.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $192.38M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $193.26M 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | $163.20M 10-K · filed 2019-02-28 |